| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 62.91B | 62.77B | 61.04B | 61.58B | 63.12B | 63.64B |
| Gross Profit | 15.92B | 15.34B | 14.42B | 14.57B | 16.03B | 16.74B |
| EBITDA | 3.84B | 3.40B | 2.24B | 2.32B | 3.63B | 4.42B |
| Net Income | 2.43B | 1.99B | 877.00M | -665.00M | 1.02B | 1.55B |
Balance Sheet | ||||||
| Total Assets | 55.22B | 56.58B | 57.97B | 57.70B | 58.23B | 57.11B |
| Cash, Cash Equivalents and Short-Term Investments | 7.75B | 7.74B | 7.21B | 7.87B | 8.10B | 6.47B |
| Total Debt | 12.33B | 13.72B | 15.03B | 15.76B | 13.63B | 12.62B |
| Total Liabilities | 25.77B | 27.20B | 29.84B | 30.85B | 29.72B | 29.06B |
| Stockholders Equity | 28.80B | 28.72B | 27.44B | 26.20B | 26.86B | 25.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.95B | -341.00M | -1.51B | 1.04B | 748.00M |
| Operating Cash Flow | 0.00 | 2.79B | 1.33B | -87.00M | 2.23B | 2.41B |
| Investing Cash Flow | 0.00 | -396.00M | -1.13B | -1.33B | -283.00M | -518.00M |
| Financing Cash Flow | 0.00 | -1.97B | -1.42B | 1.07B | -299.00M | -2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.59B | 4.67 | ― | 1.93% | -1.00% | 105.56% | |
69 Neutral | ¥15.40B | 6.15 | ― | 3.79% | -0.03% | 84.08% | |
68 Neutral | ¥41.16B | 7.42 | ― | 3.71% | -0.04% | 93.95% | |
66 Neutral | ¥3.54B | 6.84 | ― | 3.69% | 0.62% | -24.08% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥5.66B | -22.35 | ― | 2.72% | -1.30% | ― | |
53 Neutral | ¥6.81B | 45.76 | ― | 2.94% | -2.81% | 57.37% |